Conclusion
The findings of the Jordan AF study suggest that young patients
(<50 years of age) with AF tend to have better baseline
clinical characteristics, lower risk scores, and lower one-year
mortality and major bleeding rates compared to older patients. Further
studies are needed to confirm these findings and to determine the best
management strategies for young AF patients.